Profitability
Weight: 20%
D-
30
- 5yr Avg ROIC -56.0%
- Operating Margin Trend +2614.45 pp/yr
CAPR
Capricor Therapeutics, Inc.
AlphaQuality composite grade, weighted for stable earnings power businesses.
⚠ 5 of the last 5 fiscal years showed negative net income — AlphaQuality will not grade above F for persistent unprofitability in a stable earnings power business.
Grade overrides the 22.9 pillar composite — hard gates always win.
Capital Efficiency
Weight: 15%
F
0
- 5yr Avg ROE -94.2%
- 5yr Share-Count CAGR 24.5%
Growth Quality
Weight: 15%
D+
40
- Revenue-Growth Years (5) 2/5
Cash Generation
Weight: 15%
F
0
- 5yr FCF Margin -1896.9%
- 5yr FCF/NI Conversion 0.00x
Balance Sheet
Weight: 20%
F
21
- Net Debt / EBITDA 10.00x
- Interest Coverage (EBIT/Int) -33.49x
- Altman Z-Score 3.15
Stability
Weight: 15%
C-
46
- Negative-Revenue Years (5) 2/5
- Piotroski F-Score 3
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.0 of 2 gurus held; 2 full exits.
- Holders
- 0 -2
- Avg Δ position
- —
- New buys
- 0
- Full exits
- 2